Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Pannexin 1 ELISA Kit (AC2453)
Cat.#: ASET-1042
Specifications
Description Human Pannexin 1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Pannexin 1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.021 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.5-8 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1541 Mouse Notch1 ELISA Kit (AC2952) Quantitative inquiry ASET-1774 Bovine Ghrelin ELISA Kit (AC3185) Quantitative inquiry ASET-1790 Human Huntingtin ELISA Kit (AC3201) Quantitative inquiry ASET-2023 Human PAX8 ELISA Kit (AC3434) Quantitative inquiry ASET-1693 Human UCP3 ELISA Kit (AC3104) Quantitative inquiry ASET-2220 Human SOCS2 ELISA Kit (AC3631) Quantitative inquiry ASET-2173 Human NENF ELISA Kit (AC3584) Quantitative inquiry ASET-2481 Mouse BDNF ELISA Kit (AC3892) Quantitative inquiry ASET-2151 Mouse Adenosine A1 Receptor ELISA Kit (AC3562) Quantitative inquiry ASET-1359 Mouse Creatine Kinase B Type ELISA Kit (AC2770) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket